πŸ‡ΊπŸ‡Έ FDA
Patent

US 9737478

Treatment of malaria

granted A61KA61K31/137A61K31/155

Quick answer

US patent 9737478 (Treatment of malaria) held by National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR)
Grant date
Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/137, A61K31/155, A61K31/357, A61K31/365